Clinical trial
A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)
NCT07240896 is registered in ClinicalTrials.gov with DSciLab Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)
- Lead sponsor
- DSciLab Co., Ltd.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 31, 2025
- Completion date
- April 30, 2029
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
wilsons disease